Boyd Watterson Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Boyd Watterson Asset Management LLC
- $331 Million
- Q3 2025
A detailed history of Boyd Watterson Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Boyd Watterson Asset Management LLC holds 1,052 shares of REGN stock, worth $729,562. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,052
Previous 967
8.79%
Holding current value
$729,562
Previous $507,000
16.57%
% of portfolio
0.18%
Previous 0.16%
Shares
17 transactions
Others Institutions Holding REGN
# of Institutions
1,464Shares Held
86.4MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...